Andrew Solomon

2 weeks ago | jdsupra.com | Chad Landmon |Andrew Solomon

Key Takeaways The Federal Trade Commission (FTC), now under Republican leadership, has continued its scrutiny of Orange Book listings for device patents, signaling bipartisan concern over potential anti-competitive practices Despite new Warning Letters, many of the questioned patents were already delisted or tied to discontinued products, suggesting limited immediate impact on generic competition Both branded and generic drugmakers may need to reassess litigation strategies and patent...

3 weeks ago | wehotimes.com | Andrew Solomon

We all want a Church that listens. A Church that respects the community. A Church that honors process. And yet, what we’ve been handed is a Pope who was selected behind closed doors—without a single neighborhood meeting, public scoping workshop, or even a 90-minute PowerPoint on conclave outreach. There were no flyers. No e-blasts. No Vatican mailers in multiple languages. Not even a pop-up tent outside St. Peter’s with a trifold board, branded incense samples, and a clipboard.

3 weeks ago | taxjournal.com | Andrew Solomon |Peter Vaines |Veronica McMahon |Andrew Marr

If you do not subscribe but are a registered user, please enter your details in the following boxes: Username * Password * Once you have registered, you will receive an email directing you back to read this article in full.

1 month ago | tandfonline.com | Nananda Col |Andrew Solomon |Enrique Alvarez |Lori Pbert

Plain Language SummaryWhat is this summary about? The study was done to find out whether using an online tool called MS-SUPPORT can help people with multiple sclerosis (MS) and their healthcare providers (clinicians) work together when making treatment decisions. This may help people with MS start and stay with the best treatment plan and improve their quality of life. What are the key takeaways?

1 month ago | jdsupra.com | Christopher A. Jones |James Kim |Andrew Solomon

On April 15, 2025, President Trump signed the Lowering Drug Prices by Once Again Putting Americans First Executive Order (Executive Order). The Executive Order revives and expands several pharmaceutical pricing and payment reforms from President Trump’s first term, with a goal of curbing drug costs to patients. This offers a highly anticipated glimpse into the Administration’s position on drug manufacturers, Pharmacy Benefit Managers (PBMs) and providers.